Justine Orava 3/31/26 Justine Orava 3/31/26 Call for Expressions of Interest | Trainee Queensland State Representative Read More Justine Orava 3/30/26 Justine Orava 3/30/26 ESMO Asia Congress 2026 | Travel Grants for Young Oncologists Read More Justine Orava 3/2/26 Justine Orava 3/2/26 Changes to PBS indications for Nivolumab and Ipilimumab Read More Justine Orava 3/2/26 Justine Orava 3/2/26 MOGA Young Oncologist to Represent Australia at Korean Society of Medical Oncology Annual Meeting 2026 Read More Justine Orava 2/13/26 Justine Orava 2/13/26 Expression of Interest: Nominations to the Medicines Australia Code of Conduct Committee Read More Justine Orava 2/13/26 Justine Orava 2/13/26 Call for Nominations | MOGA Young Oncologists | KSMO 2026 Read More Justine Orava 10/31/25 Justine Orava 10/31/25 MOGA Executive Report – October 2025 Read More Medical Oncology Group 10/21/25 Medical Oncology Group 10/21/25 PBAC September Intracycle Outcomes – Multi-Indication Listing for Nivolumab + Ipilimumab Read More Medical Oncology Group 10/9/25 Medical Oncology Group 10/9/25 Call for Expressions of Interest: Advanced Cancer Therapeutics In Oncology Working Party Read More Medical Oncology Group 9/30/25 Medical Oncology Group 9/30/25 Health Technology Assessment (HTA) Review Implementation Advisory Group (IAG); Interim Report Released Read More Older Posts
Justine Orava 3/31/26 Justine Orava 3/31/26 Call for Expressions of Interest | Trainee Queensland State Representative Read More
Justine Orava 3/30/26 Justine Orava 3/30/26 ESMO Asia Congress 2026 | Travel Grants for Young Oncologists Read More
Justine Orava 3/2/26 Justine Orava 3/2/26 Changes to PBS indications for Nivolumab and Ipilimumab Read More
Justine Orava 3/2/26 Justine Orava 3/2/26 MOGA Young Oncologist to Represent Australia at Korean Society of Medical Oncology Annual Meeting 2026 Read More
Justine Orava 2/13/26 Justine Orava 2/13/26 Expression of Interest: Nominations to the Medicines Australia Code of Conduct Committee Read More
Justine Orava 2/13/26 Justine Orava 2/13/26 Call for Nominations | MOGA Young Oncologists | KSMO 2026 Read More
Medical Oncology Group 10/21/25 Medical Oncology Group 10/21/25 PBAC September Intracycle Outcomes – Multi-Indication Listing for Nivolumab + Ipilimumab Read More
Medical Oncology Group 10/9/25 Medical Oncology Group 10/9/25 Call for Expressions of Interest: Advanced Cancer Therapeutics In Oncology Working Party Read More
Medical Oncology Group 9/30/25 Medical Oncology Group 9/30/25 Health Technology Assessment (HTA) Review Implementation Advisory Group (IAG); Interim Report Released Read More
